Meta-analysis of Efficacy and Safety of Lentinan Injection Combined with Chemotherapy in the Treatment of Non-small Cell Lung Cancer
Ru-xu YOU,Kai-ping WANG,Pu HUANG,Hong-bo ZHOU,Yu ZHANG
DOI: https://doi.org/10.6039/j.issn.1001-0408.2014.32.20
2014-01-01
Abstract:OBJECTIVE:To evalute the clinical efficacy and safety of Lentinan injection combined with chemotherapy in the treatment of non-small cell lung cancer(NSCLC),and to provide evidence-based reference for clinical use. METHODS:Retrieved from PubMed,EMBase,Cochrane,CBM,VIP,Wanfang database and CNKI,RCTs about Lentinan injection combined with chemotherapy in the treatment of NSCLC were collected. The methodology quality evaluation of RCTs was evaluated,and Meta-analysis was conducted by using Rev Man 5.0 statistical software. RESULTS:A total of 12 RCTs were included,involving 891 patients. Meta-analysis indicated that total effective rate [RR=1.39,95%CI(1.13,1.73),P=0.002;RR=1.39,95%CI(1.03,1.88),P=0.03],improvement rate of quality life [RR=1.91,95%CI(1.49,2.45),P0.000;RR=1.98,95%CI(1.33,2.94),P0.000],the incidence of medium and severe gastrointestinal reaction [RR=0.55,95%CI(0.43,0.71),P0.000];RR=0.40,95%CI(0.18,0.87),P=0.02],the incidence of medium and severe leucopenia [RR=0.69,95%CI(0.54,0.88),P=0.003;RR=0.44,95%CI(0.25,0.78),P=0.005] of Lentinan injection combined with gemcitabine+platinum(GP scheme)or taxinol+platinum(TP scheme)were better than those of control group. Lentinan injection combined with NP scheme was better than control group of improvement rate of quality life [RR=1.79,95%CI(1.31,2.45),P0.000],but there was no statistical significance in other indications. CONCLUSIONS:Lentinan injection combined with chemotherapy in the treatment of NSCLC can improve short-term efficacy and reduce toxic effect,and long-term efficacy is to be proven.